Variable | ORUV | 95% CI | P | ORMV | 95% CI | P |
---|---|---|---|---|---|---|
Age during therapy | 1.005 | [1,1.01] | 0.0433 | 1.006 | [1,1.01] | 0.0624 |
Sex (male)a | 0.783 | [0.66,0.92] | 0.0036 | 0.824 | [0.69,0.98] | 0.0273 |
Ethnicity (UK ethnic minority)b | 1.216 | [0.88,1.68] | 0.2368 | 1.354 | [0.97,1.89] | 0.0754 |
University degree | 1.755 | [1.52,2.02] | 0.0001 | 1.371 | [1.18,1.59] | 0.0001 |
Age of onset | 1.016 | [1.01,1.02] | 0.0001 | 1.001 | [0.99,1.01] | 0.8761 |
Number of episodes | 0.914 | [0.9,0.93] | 0.0001 | 0.945 | [0.92,0.97] | 0.0001 |
Number of comorbidities | 0.867 | [0.82,0.91] | 0.0001 | 0.977 | [0.92,1.03] | 0.4089 |
Personality disorder score | 0.862 | [0.84,0.88] | 0.0001 | 0.887 | [0.87,0.91] | 0.0001 |
First therapy | 0.866 | [0.71,1.05] | 0.1524 | 0.852 | [0.69,1.05] | 0.1292 |
Main diagnosis (GAD)c | 1.155 | [1,1.34] | 0.0549 | 1.049 | [0.9,1.22] | 0.5409 |
Main diagnosis (PPD)c | 0.832 | [0.66,1.06] | 0.1294 | 1.052 | [0.82,1.35] | 0.6880 |
Therapy type (counselling)d | 1.176 | [1.02,1.35] | 0.0231 | 1.110 | [0.96,1.28] | 0.1575 |
Therapy type (group)d | 0.819 | [0.62,1.08] | 0.1581 | 0.784 | [0.59,1.04] | 0.0918 |
Concurrent medications | 0.827 | [0.7,0.97] | 0.0207 | 0.985 | [0.83,1.17] | 0.8640 |
Regular therapeutic activity | 1.441 | [1.24,1.68] | 0.0001 | 1.392 | [1.19,1.63] | 0.0001 |
Years since therapy at followup | 0.977 | [0.95,1] | 0.0910 | 0.971 | [0.94,1] | 0.0376 |